Tatjana Stankovic

41 - 50 out of 78Page size: 10
Sort by: Type

Publications

  1. Article › Research › Peer-reviewed
  2. Published

    ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

    Tatjana Stankovic, Apr 2014, In: Haematologica. 99, 4, p. 736-42 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 or ATM defective chronic lymphocytic leukemia cells

    Marwan Cheng Kuang Kwok, Nick Davies, Angelo Agathanggelou, Ceri Oldreive, Eva Petermann, Grant Stewart, Dickens Pratt, Helen Parry, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 4 Feb 2016, In: Blood. 127, 5, p. 582-595

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity

    Tatjana Stankovic, Angelo Agathanggelou & John Fossey, 27 Nov 2020, In: Tetrahedron. 76, 48, 131631.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach

    Tatjana Stankovic, Nov 2014, In: British Journal of Haematology. 167, 4, p. 565-9 5 p.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

    Tatjana Stankovic, 2015, In: Cell death & disease. 6, p. e1852

    Research output: Contribution to journal › Article › peer-review

  7. Published

    BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia

    Angelo Agathanggelou, Victoria Weston, Eva Petermann, Anastasia Zlatanou, Ceri Oldreive, Wenbin Wei, Grant Stewart, Emma Smith, Pamela Kearns & Tatjana Stankovic, Jul 2013, In: Blood Cancer Journal. 3, 7, e126.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

    Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Bod1l is required to suppress deleterious resection of stressed replication forks

    Martin Higgs, John Reynolds, Anastasia Zlatanou, Nick Davies, Tatjana Stankovic & Grant Stewart, 6 Aug 2015, In: Molecular Cell. 59, 3, p. 462-477

    Research output: Contribution to journal › Article › peer-review

  10. Published

    CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Angelo Agathanggelou, Paul Moss & 4 others, , Tatjana Stankovic, 12 Jul 2018, In: Nature. 559, 7713, p. 285-289 5 p.

    Research output: Contribution to journal › Article › peer-review

  11. E-pub ahead of print

    Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia

    Tatjana Stankovic, Ceri Oldreive & 6 others, , 2 Feb 2016, In: Blood.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 8 Next